Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].

Minerva ginecologica - 1 Apr 2004

Caserta L, Caserta R, Torella M, Perricone F, Nesti E, Sessa M, Tagliaferri A, De Francesco F, De Lucia D, Panariello S

Abstract excerpt

AIM: Hormone replacement therapy (HRT) may reduce the risk of cardiovascular events in healthy postmenopausal women. However recent studies suggest a 2-4 fold increased risk of idiopathic venous thromboembolism (VTE) among users of HRT. Our aim was to evaluate the overall effect of HRT on hemostatic variables probably related to increased VTE risk reported in epidemiological studies. METHODS: Therefore, 100...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Estrogen Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to TFPI gene

Share to Phenotype

Share to Postmenopause

Share to Progestins

Share to Syndrome

Share to Thrombophilia

Source

Identifiers

PMID: 15258541

Genes

APC
TFPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].PMID 15258541Read ↗

[Activated protein C resistance and factor V Leiden: clinical interest].Semantic proximity Read ↗

APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease.Semantic proximity Read ↗

[Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].Semantic proximity Read ↗

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.Semantic proximity Read ↗

[Activated protein C resistance as a cause of thrombophilia].Semantic proximity Read ↗

The mechanisms of thrombotic risk induced by hormone replacement therapy.Semantic proximity Read ↗

Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2.Semantic proximity Read ↗

[The significance of APC resistance (activated protein C) for clinical practice].Semantic proximity Read ↗

[Analysis of phenotype resistance to activated protein C (APC resistance)].Semantic proximity Read ↗

Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.Semantic proximity Read ↗

Prothrombin fragment 1+2 and thrombin–antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutationSemantic proximity Read ↗

Use of calibrated automated thrombinography ± thrombomodulin to recognise the prothrombotic phenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.